25 XP   0   0   10

Bionik Laboratories Corp
Buy, Hold or Sell?

Let's analyse Bionik Laboratories Corp together

PenkeI guess you are interested in Bionik Laboratories Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bionik Laboratories Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Bionik Laboratories Corp

I send you an email if I find something interesting about Bionik Laboratories Corp.

Quick analysis of Bionik Laboratories Corp (30 sec.)










What can you expect buying and holding a share of Bionik Laboratories Corp? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.13
Expected worth in 1 year
$-1.60
How sure are you?
27.3%

+ What do you gain per year?

Total Gains per Share
$-1.46
Return On Investment
-1,464.0%

For what price can you sell your share?

Current Price per Share
$0.10
Expected price per share
$0.1 - $0.1
How sure are you?
50%

1. Valuation of Bionik Laboratories Corp (5 min.)




Live pricePrice per Share (EOD)

$0.10

Intrinsic Value Per Share

$16,170.62 - $71,495.48

Total Value Per Share

$16,170.49 - $71,495.35

2. Growth of Bionik Laboratories Corp (5 min.)




Is Bionik Laboratories Corp growing?

Current yearPrevious yearGrowGrow %
How rich?-$1.6m$2.9m-$4.5m-278.4%

How much money is Bionik Laboratories Corp making?

Current yearPrevious yearGrowGrow %
Making money-$13.8b-$15.6m-$13.8b-99.9%
Net Profit Margin-766,670.2%-1,225.4%--

How much money comes from the company's main activities?

3. Financial Health of Bionik Laboratories Corp (5 min.)




4. Comparing to competitors in the Medical Care Facilities industry (5 min.)




  Industry Rankings (Medical Care Facilities)  


Richest
#172 / 187

Most Revenue
#177 / 187

Most Profit
#187 / 187

Most Efficient
#187 / 187

What can you expect buying and holding a share of Bionik Laboratories Corp? (5 min.)

Welcome investor! Bionik Laboratories Corp's management wants to use your money to grow the business. In return you get a share of Bionik Laboratories Corp.

What can you expect buying and holding a share of Bionik Laboratories Corp?

First you should know what it really means to hold a share of Bionik Laboratories Corp. And how you can make/lose money.

Speculation

The Price per Share of Bionik Laboratories Corp is $0.1. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bionik Laboratories Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bionik Laboratories Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.13. Based on the TTM, the Book Value Change Per Share is $-0.37 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bionik Laboratories Corp.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.40-396.3%-0.40-396.3%-0.83-833.9%-1.03-1,034.4%-0.74-743.7%
Usd Book Value Change Per Share-0.37-366.0%-0.37-366.0%-0.03-28.3%-0.35-354.2%-0.01-12.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.37-366.0%-0.37-366.0%-0.03-28.3%-0.35-354.2%-0.01-12.0%
Usd Price Per Share0.40-0.40-0.38-1.88-1.30-
Price to Earnings Ratio-1.01--1.01--0.45--1.94--2.35-
Price-to-Total Gains Ratio-1.09--1.09--13.23--2.29--95.71-
Price to Book Ratio-3.04--3.04-1.60-2.35--57.56-
Price-to-Total Gains Ratio-1.09--1.09--13.23--2.29--95.71-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.1
Number of shares10000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.37-0.35
Usd Total Gains Per Share-0.37-0.35
Gains per Quarter (10000 shares)-3,659.98-3,542.13
Gains per Year (10000 shares)-14,639.92-14,168.52
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-14640-146500-14169-14179
20-29280-292900-28337-28348
30-43920-439300-42506-42517
40-58560-585700-56674-56686
50-73200-732100-70843-70855
60-87839-878500-85011-85024
70-102479-1024900-99180-99193
80-117119-1171300-113348-113362
90-131759-1317700-127517-127531
100-146399-1464100-141685-141700

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.011.00.00.0%0.013.00.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%3.08.00.027.3%4.09.00.030.8%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.011.00.0%0.00.013.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%3.08.00.027.3%4.09.00.030.8%

Fundamentals of Bionik Laboratories Corp

About Bionik Laboratories Corp

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.

Fundamental data was last updated by Penke on 2024-03-26 05:17:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Bionik Laboratories Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bionik Laboratories Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Bionik Laboratories Corp to the Medical Care Facilities industry mean.
  • A Net Profit Margin of -766,670.2% means that $-7,666.70 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bionik Laboratories Corp:

  • The MRQ is -766,670.2%. The company is making a huge loss. -2
  • The TTM is -766,670.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-766,670.2%TTM-766,670.2%0.0%
TTM-766,670.2%YOY-1,225.4%-765,444.8%
TTM-766,670.2%5Y-154,109.7%-612,560.5%
5Y-154,109.7%10Y-70,315.7%-83,794.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-766,670.2%2.2%-766,672.4%
TTM-766,670.2%2.1%-766,672.3%
YOY-1,225.4%3.4%-1,228.8%
5Y-154,109.7%2.9%-154,112.6%
10Y-70,315.7%3.6%-70,319.3%
1.1.2. Return on Assets

Shows how efficient Bionik Laboratories Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bionik Laboratories Corp to the Medical Care Facilities industry mean.
  • -411,642.6% Return on Assets means that Bionik Laboratories Corp generated $-4,116.43 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bionik Laboratories Corp:

  • The MRQ is -411,642.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -411,642.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-411,642.6%TTM-411,642.6%0.0%
TTM-411,642.6%YOY-333.8%-411,308.8%
TTM-411,642.6%5Y-82,460.9%-329,181.7%
5Y-82,460.9%10Y-37,603.4%-44,857.5%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-411,642.6%0.7%-411,643.3%
TTM-411,642.6%0.6%-411,643.2%
YOY-333.8%1.0%-334.8%
5Y-82,460.9%0.8%-82,461.7%
10Y-37,603.4%1.0%-37,604.4%
1.1.3. Return on Equity

Shows how efficient Bionik Laboratories Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bionik Laboratories Corp to the Medical Care Facilities industry mean.
  • 0.0% Return on Equity means Bionik Laboratories Corp generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bionik Laboratories Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-533.2%+533.2%
TTM-5Y-236.9%+236.9%
5Y-236.9%10Y-132.1%-104.8%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.0%-2.0%
TTM-2.1%-2.1%
YOY-533.2%2.5%-535.7%
5Y-236.9%2.1%-239.0%
10Y-132.1%2.5%-134.6%

1.2. Operating Efficiency of Bionik Laboratories Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bionik Laboratories Corp is operating .

  • Measures how much profit Bionik Laboratories Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bionik Laboratories Corp to the Medical Care Facilities industry mean.
  • An Operating Margin of -267.3% means the company generated $-2.67  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bionik Laboratories Corp:

  • The MRQ is -267.3%. The company is operating very inefficient. -2
  • The TTM is -267.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-267.3%TTM-267.3%0.0%
TTM-267.3%YOY-374.7%+107.4%
TTM-267.3%5Y-380.9%+113.6%
5Y-380.9%10Y-459.6%+78.7%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-267.3%7.9%-275.2%
TTM-267.3%6.8%-274.1%
YOY-374.7%6.6%-381.3%
5Y-380.9%6.4%-387.3%
10Y-459.6%8.0%-467.6%
1.2.2. Operating Ratio

Measures how efficient Bionik Laboratories Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • An Operation Ratio of 3.67 means that the operating costs are $3.67 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bionik Laboratories Corp:

  • The MRQ is 3.673. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.673. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.673TTM3.6730.000
TTM3.673YOY4.747-1.074
TTM3.6735Y4.937-1.264
5Y4.93710Y5.558-0.621
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6731.166+2.507
TTM3.6731.128+2.545
YOY4.7470.992+3.755
5Y4.9371.021+3.916
10Y5.5581.001+4.557

1.3. Liquidity of Bionik Laboratories Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bionik Laboratories Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A Current Ratio of 1.20 means the company has $1.20 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bionik Laboratories Corp:

  • The MRQ is 1.203. The company is just able to pay all its short-term debts.
  • The TTM is 1.203. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.203TTM1.2030.000
TTM1.203YOY3.073-1.870
TTM1.2035Y1.476-0.273
5Y1.47610Y0.942+0.535
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2031.286-0.083
TTM1.2031.308-0.105
YOY3.0731.383+1.690
5Y1.4761.386+0.090
10Y0.9421.413-0.471
1.3.2. Quick Ratio

Measures if Bionik Laboratories Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bionik Laboratories Corp to the Medical Care Facilities industry mean.
  • A Quick Ratio of 0.38 means the company can pay off $0.38 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bionik Laboratories Corp:

  • The MRQ is 0.381. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.381. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.381TTM0.3810.000
TTM0.381YOY1.519-1.138
TTM0.3815Y0.841-0.459
5Y0.84110Y1.391-0.550
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3810.941-0.560
TTM0.3810.961-0.580
YOY1.5191.037+0.482
5Y0.8411.182-0.341
10Y1.3911.125+0.266

1.4. Solvency of Bionik Laboratories Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bionik Laboratories Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bionik Laboratories Corp to Medical Care Facilities industry mean.
  • A Debt to Asset Ratio of 1.49 means that Bionik Laboratories Corp assets are financed with 148.8% credit (debt) and the remaining percentage (100% - 148.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bionik Laboratories Corp:

  • The MRQ is 1.488. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.488. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.488TTM1.4880.000
TTM1.488YOY0.374+1.114
TTM1.4885Y0.575+0.913
5Y0.57510Y1.958-1.382
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4880.543+0.945
TTM1.4880.548+0.940
YOY0.3740.518-0.144
5Y0.5750.564+0.011
10Y1.9580.533+1.425
1.4.2. Debt to Equity Ratio

Measures if Bionik Laboratories Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bionik Laboratories Corp to the Medical Care Facilities industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bionik Laboratories Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.597-0.597
TTM-5Y0.557-0.557
5Y0.55710Y2.951-2.394
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.928-0.928
TTM-0.960-0.960
YOY0.5971.061-0.464
5Y0.5571.214-0.657
10Y2.9511.198+1.753

2. Market Valuation of Bionik Laboratories Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Bionik Laboratories Corp generates.

  • Above 15 is considered overpriced but always compare Bionik Laboratories Corp to the Medical Care Facilities industry mean.
  • A PE ratio of -1.01 means the investor is paying $-1.01 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bionik Laboratories Corp:

  • The EOD is -0.252. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.009. Based on the earnings, the company is expensive. -2
  • The TTM is -1.009. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.252MRQ-1.009+0.757
MRQ-1.009TTM-1.0090.000
TTM-1.009YOY-0.450-0.560
TTM-1.0095Y-1.939+0.930
5Y-1.93910Y-2.347+0.407
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD-0.25212.021-12.273
MRQ-1.00910.707-11.716
TTM-1.00913.872-14.881
YOY-0.45011.719-12.169
5Y-1.93913.630-15.569
10Y-2.34719.358-21.705
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bionik Laboratories Corp:

  • The EOD is 0.000. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 0.000. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 0.000. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.000MRQ0.0000.000
MRQ0.000TTM0.0000.000
TTM0.000YOY-1.125+1.125
TTM0.0005Y-3.212+3.212
5Y-3.21210Y-193.676+190.465
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD0.0008.697-8.697
MRQ0.0007.243-7.243
TTM0.0006.361-6.361
YOY-1.1255.539-6.664
5Y-3.2126.152-9.364
10Y-193.6765.110-198.786
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bionik Laboratories Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A PB ratio of -3.04 means the investor is paying $-3.04 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bionik Laboratories Corp:

  • The EOD is -0.761. Based on the equity, the company is expensive. -2
  • The MRQ is -3.043. Based on the equity, the company is expensive. -2
  • The TTM is -3.043. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.761MRQ-3.043+2.282
MRQ-3.043TTM-3.0430.000
TTM-3.043YOY1.599-4.642
TTM-3.0435Y2.347-5.390
5Y2.34710Y-57.558+59.905
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD-0.7611.989-2.750
MRQ-3.0432.117-5.160
TTM-3.0432.028-5.071
YOY1.5992.291-0.692
5Y2.3472.374-0.027
10Y-57.5582.685-60.243
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Bionik Laboratories Corp.

3.1. Insider Transactions

Insiders are holding 80.004% of the shares of Bionik Laboratories Corp.

DateOwnerTypeAmountPricePost Transaction AmountLink
2021-03-29Matine CharlesBUY2643026430
2021-03-29Malone Peter GeraldBUY2643026430
2021-03-29Martin Joseph RBUY2643026430
2021-03-29Thevenon AudreyBUY2643026430
2021-03-26Auberton-herve Andre-jacquesBUY9514995149
2019-08-26Gaston-dreyfus RemiBUY1063583.761201412
2019-03-28Auberton-herve Andre-jacquesBUY814923.89224475
2018-07-24Gaston-dreyfus RemiBUY434685470.05134672664
2018-06-13Gaston-dreyfus RemiBUY157407280.0691204117

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Bionik Laboratories Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.366-0.3660%-0.028-92%-0.354-3%-0.012-97%
Book Value Per Share---0.131-0.1310%0.235-156%0.726-118%0.657-120%
Current Ratio--1.2031.2030%3.073-61%1.476-19%0.942+28%
Debt To Asset Ratio--1.4881.4880%0.374+298%0.575+159%1.958-24%
Debt To Equity Ratio----0%0.597-100%0.557-100%2.951-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.396-0.3960%-0.834+110%-1.034+161%-0.744+88%
Free Cash Flow Per Share--4020.8344020.8340%-0.333+100%803.729+400%365.154+1001%
Free Cash Flow To Equity Per Share--4020.9984020.9980%0.111+3609682%804.223+400%365.567+1000%
Gross Profit Margin--1.0001.0000%1.123-11%1.101-9%1.086-8%
Intrinsic Value_10Y_max--71495.483--------
Intrinsic Value_10Y_min--16170.619--------
Intrinsic Value_1Y_max--2601.559--------
Intrinsic Value_1Y_min--688.614--------
Intrinsic Value_3Y_max--11294.010--------
Intrinsic Value_3Y_min--2888.314--------
Intrinsic Value_5Y_max--24178.883--------
Intrinsic Value_5Y_min--5969.081--------
Market Cap1248040.000-300%4992160.0004992160.0000%4680150.000+7%23400750.000-79%16186511.509-69%
Net Profit Margin---7666.702-7666.7020%-12.254-100%-1541.097-80%-703.157-91%
Operating Margin---2.673-2.6730%-3.747+40%-3.809+43%-4.596+72%
Operating Ratio--3.6733.6730%4.747-23%4.937-26%5.558-34%
Pb Ratio-0.761+75%-3.043-3.0430%1.599-290%2.347-230%-57.558+1792%
Pe Ratio-0.252+75%-1.009-1.0090%-0.450-55%-1.939+92%-2.347+132%
Price Per Share0.100-300%0.4000.4000%0.375+7%1.875-79%1.297-69%
Price To Free Cash Flow Ratio0.000-300%0.0000.0000%-1.125+1131054%-3.212+3228555%-193.676+194685131%
Price To Total Gains Ratio-0.273+75%-1.093-1.0930%-13.228+1110%-2.286+109%-95.707+8657%
Quick Ratio--0.3810.3810%1.519-75%0.841-55%1.391-73%
Return On Assets---4116.426-4116.4260%-3.338-100%-824.609-80%-376.034-91%
Return On Equity----0%-5.3320%-2.3690%-1.3210%
Total Gains Per Share---0.366-0.3660%-0.028-92%-0.354-3%-0.012-97%
Usd Book Value---1640588.000-1640588.0000%2927212.000-156%9058512.400-118%8194492.455-120%
Usd Book Value Change Per Share---0.366-0.3660%-0.028-92%-0.354-3%-0.012-97%
Usd Book Value Per Share---0.131-0.1310%0.235-156%0.726-118%0.657-120%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.396-0.3960%-0.834+110%-1.034+161%-0.744+88%
Usd Free Cash Flow--50181612686.00050181612686.0000%-4159787.000+100%10030854324.800+400%4557262454.364+1001%
Usd Free Cash Flow Per Share--4020.8344020.8340%-0.333+100%803.729+400%365.154+1001%
Usd Free Cash Flow To Equity Per Share--4020.9984020.9980%0.111+3609682%804.223+400%365.567+1000%
Usd Market Cap1248040.000-300%4992160.0004992160.0000%4680150.000+7%23400750.000-79%16186511.509-69%
Usd Price Per Share0.100-300%0.4000.4000%0.375+7%1.875-79%1.297-69%
Usd Profit---13839946024.000-13839946024.0000%-15608602.000-100%-2781000724.200-80%-1266206307.182-91%
Usd Revenue--1805202.0001805202.0000%1273712.000+42%1934347.200-7%1022028.364+77%
Usd Total Gains Per Share---0.366-0.3660%-0.028-92%-0.354-3%-0.012-97%
 EOD+3 -5MRQTTM+0 -0YOY+17 -165Y+13 -2010Y+15 -18

4.2. Fundamental Score

Let's check the fundamental score of Bionik Laboratories Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.252
Price to Book Ratio (EOD)Between0-1-0.761
Net Profit Margin (MRQ)Greater than0-7,666.702
Operating Margin (MRQ)Greater than0-2.673
Quick Ratio (MRQ)Greater than10.381
Current Ratio (MRQ)Greater than11.203
Debt to Asset Ratio (MRQ)Less than11.488
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-4,116.426
Total2/10 (20.0%)

4.3. Technical Score

Let's check the technical score of Bionik Laboratories Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.890
Ma 20Greater thanMa 500.100
Ma 50Greater thanMa 1000.100
Ma 100Greater thanMa 2000.100
OpenGreater thanClose0.100
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-03-312020-03-312021-03-312022-03-312023-03-31
Total Stockholder Equity 27,408-14,09113,317-10,0363,281-3542,927-4,568-1,641
Long-term Assets Other  -26,92914,238-12,6907,337-5,3535,262-911009



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets3,362
Total Liabilities5,003
Total Stockholder Equity-1,641
 As reported
Total Liabilities 5,003
Total Stockholder Equity+ -1,641
Total Assets = 3,362

Assets

Total Assets3,362
Total Current Assets2,778
Long-term Assets585
Total Current Assets
Cash And Cash Equivalents 427
Net Receivables 453
Inventory 1,034
Total Current Assets  (as reported)2,778
Total Current Assets  (calculated)1,915
+/- 863
Long-term Assets
Property Plant Equipment 442
Goodwill 100
Intangible Assets 34
Other Assets 9
Long-term Assets  (as reported)585
Long-term Assets  (calculated)585
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,309
Long-term Liabilities2,694
Total Stockholder Equity-1,641
Total Current Liabilities
Short-term Debt 22
Accounts payable 558
Other Current Liabilities 1,387
Total Current Liabilities  (as reported)2,309
Total Current Liabilities  (calculated)1,967
+/- 342
Long-term Liabilities
Long term Debt 2,156
Capital Lease Obligations Min Short Term Debt234
Other Liabilities 303
Long-term Liabilities  (as reported)2,694
Long-term Liabilities  (calculated)2,694
+/-0
Total Stockholder Equity
Common Stock7
Retained Earnings -100,348
Accumulated Other Comprehensive Income 30
Other Stockholders Equity 98,671
Total Stockholder Equity (as reported)-1,641
Total Stockholder Equity (calculated)-1,641
+/-0
Other
Capital Stock7
Cash and Short Term Investments 427
Common Stock Shares Outstanding 6,904
Current Deferred Revenue342
Liabilities and Stockholders Equity 3,362
Net Debt 1,985
Net Invested Capital 515
Net Tangible Assets -1,774
Net Working Capital 468
Property Plant and Equipment Gross 1,102
Short Long Term Debt Total 2,412



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-12-312015-03-312014-03-312013-03-312012-03-312011-03-31
> Total Assets 
8
12
5
4
3
7,238
6,237
28,969
28,585
30,678
18,517
8,786
4,676
3,362
3,3624,6768,78618,51730,67828,58528,9696,2377,238345128
   > Total Current Assets 
8
12
5
4
3
7,151
6,160
1,403
1,410
3,749
5,827
3,433
4,585
2,778
2,7784,5853,4335,8273,7491,4101,4036,1607,151345128
       Cash And Cash Equivalents 
8
12
5
4
3
6,617
5,382
544
507
447
2,270
608
1,991
427
4271,9916082,2704475075445,3826,617345128
       Net Receivables 
0
0
0
0
401
401
458
425
241
2,897
911
2,132
275
453
4532752,1329112,8972414254584014010000
       Other Current Assets 
0
0
0
0
0
534
320
205
425
1,374
1,586
1,680,557,000
1,127
862,603,000
862,603,0001,1271,680,557,0001,5861,37442520532053400000
   > Long-term Assets 
0
0
0
0
0
0
77
27,566
27,175
26,929
12,690
5,353
91
585
585915,35312,69026,92927,17527,56677000000
       Property Plant Equipment 
0
0
0
0
78
87
77
227
160
193
154
94
91
442
44291941541931602277787780000
       Goodwill 
0
0
0
0
0
0
0
22,308
22,308
22,308
11,086
4,283
0
100
10004,28311,08622,30822,30822,3080000000
       Intangible Assets 
0
0
0
0
0
0
0
5,031
4,707
4,428
1,450
977
0
34
3409771,4504,4284,7075,0310000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
9
90000000000000
> Total Liabilities 
6
6
2
14
43
6,260
5,973
5,778
8,122
3,270
5,200
5,505
1,749
5,003
5,0031,7495,5055,2003,2708,1225,7785,9736,2604314266
   > Total Current Liabilities 
0
6
2
14
43
6,260
5,973
5,778
8,122
3,270
5,200
4,095
1,492
2,309
2,3091,4924,0955,2003,2708,1225,7785,9736,2604314260
       Short-term Debt 
0
6
0
0
0
6,068
5,136
2,585
51
0
2,079
2,612
0
22
2202,6122,0790512,5855,1366,06800060
       Short Long Term Debt 
0
0
0
0
0
6,068
5,136
2,585
51
0
2,079
2,612
0
0
002,6122,0790512,5855,1366,06800000
       Accounts payable 
0
0
0
0
16
135
321
785
725
1,149
857
455
305
558
5583054558571,149725785321135160000
       Other Current Liabilities 
0
0
2
14
26
6,068
5,652
2,188
7,222
1,653
1,648
760
873
1,387
1,3878737601,6481,6537,2222,1885,6526,0682614200
   > Long-term Liabilities 
6
6
0
0
16
0
321
3,590
900
1,617
416
1,410
257
2,694
2,6942571,4104161,6179003,5903210160066
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
416
304
257
303
3032573044160000000000
> Total Stockholder Equity
2
6
3
-10
-39
978
264
23,191
20,463
27,408
13,317
3,281
2,927
-1,641
-1,6412,9273,28113,31727,40820,46323,191264978-39-10362
   Common Stock
5
5
5
116
97
72
73
97
250
4
5
6
7
7
7765425097737297116555
   Retained Earnings -100,348-95,402-84,994-71,374-46,357-35,776-15,589-11,652-10,648-65-35-22-13-8
   Capital Surplus 00000000000000
   Treasury Stock00000000000000
   Other Stockholders Equity 
5
14
20
-91
-71
141
11,801
38,641
55,948
73,719
84,644
88,228
98,295
98,671
98,67198,29588,22884,64473,71955,94838,64111,801141-71-9120145



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue1,805
Cost of Revenue-815
Gross Profit990990
 
Operating Income (+$)
Gross Profit990
Operating Expense-5,815
Operating Income-4,825-4,825
 
Operating Expense (+$)
Research Development903
Selling General Administrative2,930
Selling And Marketing Expenses1,982
Operating Expense5,8155,815
 
Net Interest Income (+$)
Interest Income0
Interest Expense-107
Other Finance Cost-0
Net Interest Income-107
 
Pretax Income (+$)
Operating Income-4,825
Net Interest Income-107
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-4,946-4,704
EBIT - interestExpense = -4,932
-4,946
-13,839,839
Interest Expense107
Earnings Before Interest and Taxes (EBIT)-4,825-4,839
Earnings Before Interest and Taxes (EBITDA)-4,776
 
After tax Income (+$)
Income Before Tax-4,946
Tax Provision-0
Net Income From Continuing Ops-4,946-4,946
Net Income-13,839,946
Net Income Applicable To Common Shares-4,946
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses6,630
Total Other Income/Expenses Net-121107
 

Technical Analysis of Bionik Laboratories Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bionik Laboratories Corp. The general trend of Bionik Laboratories Corp is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bionik Laboratories Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bionik Laboratories Corp.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.1 < 0.1 < 0.1.

The bearish price targets are: 0.1 > 0.1 > 0.1.

Tweet this
Bionik Laboratories Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bionik Laboratories Corp. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bionik Laboratories Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bionik Laboratories Corp. The current macd is -0.000030.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bionik Laboratories Corp price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Bionik Laboratories Corp. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Bionik Laboratories Corp price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Bionik Laboratories Corp Daily Moving Average Convergence/Divergence (MACD) ChartBionik Laboratories Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bionik Laboratories Corp. The current adx is 42.50.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Bionik Laboratories Corp shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Bionik Laboratories Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bionik Laboratories Corp. The current sar is 0.08288219.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Bionik Laboratories Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bionik Laboratories Corp. The current rsi is 32.89. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Bionik Laboratories Corp Daily Relative Strength Index (RSI) ChartBionik Laboratories Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bionik Laboratories Corp. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bionik Laboratories Corp price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Bionik Laboratories Corp Daily Stochastic Oscillator ChartBionik Laboratories Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bionik Laboratories Corp. The current cci is -66.66666667.

Bionik Laboratories Corp Daily Commodity Channel Index (CCI) ChartBionik Laboratories Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bionik Laboratories Corp. The current cmo is -41.23666746.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Bionik Laboratories Corp Daily Chande Momentum Oscillator (CMO) ChartBionik Laboratories Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bionik Laboratories Corp. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Bionik Laboratories Corp Daily Williams %R ChartBionik Laboratories Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bionik Laboratories Corp.

Bionik Laboratories Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bionik Laboratories Corp. The current atr is 0.0000.

Bionik Laboratories Corp Daily Average True Range (ATR) ChartBionik Laboratories Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bionik Laboratories Corp. The current obv is 152,400.

Bionik Laboratories Corp Daily On-Balance Volume (OBV) ChartBionik Laboratories Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bionik Laboratories Corp. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Bionik Laboratories Corp Daily Money Flow Index (MFI) ChartBionik Laboratories Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bionik Laboratories Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Bionik Laboratories Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bionik Laboratories Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.890
Ma 20Greater thanMa 500.100
Ma 50Greater thanMa 1000.100
Ma 100Greater thanMa 2000.100
OpenGreater thanClose0.100
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Bionik Laboratories Corp with someone you think should read this too:
  • Are you bullish or bearish on Bionik Laboratories Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bionik Laboratories Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bionik Laboratories Corp

I send you an email if I find something interesting about Bionik Laboratories Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Bionik Laboratories Corp.

Receive notifications about Bionik Laboratories Corp in your mailbox!